Induction of tolerance in clinical organ transplantation

Nephrology Dialysis Transplantation

Volumn 21, Issue 5, 2006, Pages 1170-1173

  Fandrich F ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

Mixed chimerism; Regulatory cells; Tolerance

Indexed keywords

CD3 ANTIBODY; CD40 LIGAND MONOCLONAL ANTIBODY; COLONY STIMULATING FACTOR 1; CYTOKINE; GAMMA INTERFERON; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 10; INTERLEUKIN 2; MONOCLONAL ANTIBODY CD28; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ADOPTIVE IMMUNOTHERAPY; ALLOTRANSPLANTATION; BONE MARROW DISEASE; BONE MARROW TRANSPLANTATION; CHIMERA; CLINICAL TRIAL; DRUG CHOICE; DRUG EFFICACY; DRUG FATALITY; DRUG MEGADOSE; DRUG SAFETY; GRAFT SURVIVAL; HLA MATCHING; HUMAN; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LONG TERM CARE; LYMPHOCYTE SUBPOPULATION; MONOCYTE; NONHUMAN; NONMYELOABLATIVE CONDITIONING; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; SHORT COURSE THERAPY; SURVIVAL TIME; T LYMPHOCYTE ACTIVATION; THROMBOEMBOLISM; TRANSPLANTATION TOLERANCE;

ANIMALS; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNE TOLERANCE; ORGAN TRANSPLANTATION; PROGNOSIS; RISK ASSESSMENT; TRANSPLANTATION CHIMERA; TRANSPLANTATION CONDITIONING; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION TOLERANCE; TRANSPLANTATION, HOMOLOGOUS;

EID: 33646178176     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfl055     Document Type: Review

References (31)

1. Billingham RE, Brent L, Medawar PB. Actively acquired tolerance of foreign cells. Nature 1953; 172: 603-606
2. Ildstad ST, Sachs DH. Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature 1984; 307: 168-170
3. Sharabi Y, Sachs DH. Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen. J Exp Med 1989; 169: 493-502
4. Kawai T et al. Mixed allogeneic chimerism and renal allograft tolerance in cynomolgus monkeys. Transplantation 1995; 59: 256-262
5. Wekerle T et al. Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment. Nat Med 2000; 6: 464-469
6. Durham MM et al. Cutting edge: Administration of anti-CD40 ligand and donor bone marrow leads to hemopoietic chimerism and donor-specific tolerance without cytoreductive conditioning. Immunol 2000; 165: 1-4
7. Kawai T, Andrews D, Colvin RB, Sachs DH, Cosimi AB. Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand. Nat Med 2000; 6: 114
8. Spitzer TR et al. Combined histocompatibility leukocyte antigen-matched donor bone marrow and renal transplantation for multiple myeloma with end stage renal disease: The induction of allograft tolerance through mixed lymphohematopoietic chimerism. Transplantation 1999; 68: 480-484
9. Buhler LH et al. Induction of kidney allograft tolerance after transient lymphohematopoietic chimerism in patients with multiple myeloma and end-stage renal disease. Transplantation 2002; 74: 1405-1409
10. Awwad M, North RJ. Immunologically mediated regression of a murine lymphoma after treatment with anti-L3T4 antibody. A consequence of removing L3T4+ suppressor T cells from a host generating predominantly Lyt-2+ T cell-mediated immunity. J Exp Med 1988; 168: 2193-2206
11. Sakaguchi S, Takahashi T, Nishizuka Y. Study on cellular events in post-thymectomy autoimmune oophoritis in mice. II. Requirement of Lyt-1 cells in normal female mice for the prevention of oophoritis. J Exp Med 1982; 156: 1577-1586
12. Sakaguchi S. Regulatory T cells: Key controllers of immunologic self-tolerance. Cell 2000; 101: 455-458
13. Horwitz DA et al. Regulatory T cells generated ex vivo as an approach for the therapy of autoimmune disease. Semin Immunol 2004; 16: 135-143
14. Roncarolo MG, Bacchetta R, Bordignon C, Narula S, Levings MK. Type 1 T regulatory cells. Immuno Rev 2001; 182: 68-79
15. + immune regulatory cells inhibits graft-versus-host disease lethality. Blood 2002; 99: 3493-3499
16. + T suppressor cell clones produce transforming growth factor β, but not interleukin 10, and are distinct from type 1T regulatory cells. J Exp Med 2002; 196: 1335-1346
17. + T-regulatory cells can markedly inhibit allogeneic dendritic cell-stimulated MLR cultures. Blood 2004; 104: 453-461
18. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997; 389: 737-742
19. H2-inducing cytokines. J Exp Med 2002; 195: 603-616
20. H3 regulatory cells. Immunol Rev 2001; 182: 207-214
21. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 1998; 188: 287-296
22. + regulatory T cell function. Eur J Immunol 2004; 34: 2996-3005
23. + T suppressor cells mediate tolerance to allogeneic heart transplants, inducing PIR-B in APC and rendering the graft invulnerable to rejection. Transpl Immunol 2004; 13: 239-247
24. + regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses. J Immunol 2002; 168: 1080-1086
25. Waldmann H et al. Regulatory T cells and organ transplantation. Semin Immunol 2004; 16: 119-126
26. Chang CC, Ciubotariu R, Manavalan JS et al. Tolerization of dendritic cells by T cells: The crucial role of inhibitory receptors ILT3 and ILT4. Nat Immunol 2002; 3: 237-243
27. + regulatory T cells. Blood 2004; 104: 895-903
28. Tang Q et al. In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J Exp Med 2004; 199: 1455-1465
29. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 2004; 25: 677-686
30. Mosser DM. The many faces of macrophage activation. J Leuk Biol 2003; 73: 209-212
31. Fändrich F, Lin X, Chai GX et al. Preimplantation-stage stem cells induce long-term allogeneic graft acceptance without supplementary host conditioning. Nat Med 2002; 8: 171-178